Report by the Director-General. 75th World health assembly 25 April 2022
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Depression Research and Treatment
Volume 2012, Article ID 962860, 8 pages
doi:10.1155/2012/962860
DEPRESSION AND ANXIETY 27 : 390–403 (2010
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatment of these disorders
Mental Health Policy, Planning & Service Development
When trying to stop engaging in non-suicidal self-injury, it can take time to find new ways to cope
If you notice changes in the person’s mood, behaviour, energy levels, habits or
personality, you should consider depression as a possible reason for these changes.
However, you should not attempt to diagnose the person with depression, as only a
trained professional can do this. Do not ignore t...he symptoms you have noticed or
assume that they will just go away
more
NICE guideline
Published: 23 May 2017
The Georgetown Undergraduate Journal of Health Services (2), 2012.
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of... users as well as to others and society at large. It provides WHO recommendations for the most effective prevention measures in Viet Nam and will also help answer questions that policy makers may have on how to develop effective policies for prevention and control of alcohol related harms.
more
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
multidisciplinary approach to the drugs phenomenon at
national, EU and international level. It also incorporates a
gender equality and health equity perspective.
more
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...elated matters’,1 and derived
from the landmark UN System Common Position on Drug
more
a systematic analysis for the Global Burden of Disease Study 2016.
The Lancet Published:November 01, 2018DOI:https://doi.org/10.1016/S2215-0366(18)30337-7